Vistagen Therapeutics (VTGN) Change in Accured Expenses (2010 - 2026)
Vistagen Therapeutics (VTGN) reported Change in Accured Expenses of -$53,000 for fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$2.42 million a year earlier.
Vistagen Therapeutics (VTGN) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Vistagen Therapeutics' Change in Accured Expenses came in at $3.2 million, down 13.8% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $828,000, down 85.4% from FY2025.
- Change in Accured Expenses has a five-year compound annual growth rate of 74.6% (FY2021 to FY2026).
- By fiscal year, Change in Accured Expenses came in at $5.68 million in FY2025 (+988.3%), $522,000 in FY2024, -$934,000 in FY2023 and $1.69 million in FY2022.
- Five-year quarterly Change in Accured Expenses spans a low of -$2.42 million in fiscal Q1 2026 and a high of $3.69 million in fiscal Q2 2022.
- Year over year, Change in Accured Expenses gained in three of the last four quarters, with growth averaging 192.6%.
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at -$243,000 (Q4 2026), $294,000 (Q3 2026) and $3.2 million (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 2.96 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -251.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Vistagen Therapeutics | 12.43 Mn | 12.43 Mn | - | -53,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -53,000.00 |
| Mar 31, 2026 | -243,000.00 |
| Dec 31, 2025 | 294,000.00 |
| Sep 30, 2025 | 3.20 Mn |
| Jun 30, 2025 | -2.42 Mn |
| Mar 31, 2025 | 2.96 Mn |
| Dec 31, 2024 | 1.98 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | -455,000.00 |
| Mar 31, 2024 | 1.92 Mn |
| Dec 31, 2023 | 269,000.00 |
| Sep 30, 2023 | -450,000.00 |
| Jun 30, 2023 | -1.21 Mn |
| Mar 31, 2023 | 575,500.00 |
| Dec 31, 2022 | -1.46 Mn |
| Sep 30, 2022 | -2.05 Mn |
| Jun 30, 2022 | 2.01 Mn |
| Mar 31, 2022 | -488,400.00 |
| Dec 31, 2021 | -1.51 Mn |
| Sep 30, 2021 | 1.62 Mn |
Vistagen Therapeutics Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=VTGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();